Overall survival of study population. Overall survival according to onset of immune‐related adverse events (A), neutrophil‐to‐lymphocyte ratio (B), and platelet‐to‐lymphocyte ratio (C).
Abbreviations: irAE, immune‐related adverse event; NLR, neutrophil‐to‐lymphocyte ratio; PLR, platelet‐to‐lymphocyte ratio.